Inventor · disambiguated record
Charles G. Drake
Also filed as: DRAKE CHARLES · DRAKE CHARLES C · DRAKE CHARLES G · DRAKE CHARLES GEORGE
10 granted patents·18 pending applications·167 citations·filing 2004–2023
89Inventor score
Top patents by PatentIndex Score
28 records- 0196US9005629B2Method for treating cancer with an antibody to CD223 proteinUNIV JOHNS HOPKINS·Filed 2012·Granted Apr 14, 2015·42 cites·4 claims
- 0294US9132281B2Focused radiation for augmenting immune-based therapies against neoplasmsZENG JING·Filed 2012·Granted Sep 15, 2015·68 cites·16 claims
- 0393US8551481B2Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibodyPARDOLL DREW M·Filed 2009·Granted Oct 8, 2013·41 cites·6 claims
- 0488US9808516B2Immunogenic fusion proteins for the treatment of cancerADURO BIOTECH INC·Filed 2016·Granted Nov 7, 2017·6 cites·9 claims
- 0584US2024174747A1T cell regulationUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0680US9523126B2Compositions and methods for modulating an immune responseUNIV JOHNS HOPKINS·Filed 2014·Granted Dec 20, 2016·3 cites·6 claims
- 0779US10787513B2Methods for treatment comprising an antibody that binds CD223 proteinUNIV JOHNS HOPKINS·Filed 2015·Granted Sep 29, 2020·1 cites·25 claims
- 0874US9585957B2Adenosine receptor agonists and antagonists to modulate T cell responsesPOWELL JONATHAN D·Filed 2008·Granted Mar 7, 2017·6 cites·5 claims
- 0974US2021230275A1T cell regulationUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1072US10934354B2Methods of increasing T cell immune response in the treatment of cancerUNIV JOHNS HOPKINS·Filed 2018·Granted Mar 2, 2021·0 cites·20 claims
- 1168US2014127226A1T Cell RegulationST JUDE S CHILDREN S RES HOSPITAL INC·Filed 2013·Application pending·0 cites
- 1266US2024108644A1Tumor immunotherapyUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 1364US2006240024A1T cell regulationST JUDE CHILDRENS RES HOSPITAL·Filed 2004·Application pending·0 cites
- 1464US2024269203A1Oncolytic virus and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1561US2011229498A1Compositions and methods for modulating an immune responseUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 1660US10329617B2Compositions and methods for modulating an immune responseUNIV JOHNS HOPKINS·Filed 2016·Granted Jun 25, 2019·0 cites·18 claims
- 1759US9248170B2Immunogenic compositions and methods for treating neoplasiaKIM YOUNG JUN·Filed 2012·Granted Feb 2, 2016·0 cites·20 claims
- 1854US2023285548A1Vaccines based on mutant calr and jak2 and their usesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1954US2018085446A1Immunogenic Fusion Proteins For The Treatment Of CancerADURO BIOTECH INC·Filed 2017·Application pending·0 cites
- 2054US2023190903A1Prostate cancer vaccines and uses thereofJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2152US2015050288A1Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3UNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 2250US2022040252A1Treatment of prostate cancer by androgen ablation and il-8 blockadeUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 2349US2011195509A1Treatment of th17-mediated autoimmune disease via inhibition of stat 3PARDOLL DREW·Filed 2008·Application pending·0 cites
- 2447US2019240327A9Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonistsUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 2546US2009304711A1Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 AntibodiesPARDOLL DREW·Filed 2007·Application pending·0 cites
- 2643US2010040636A1Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and AntagonistsUNIV JOHNS HOPKINS·Filed 2006·Application pending·0 cites
- 2741US2017143726A1Adenosine receptor agonists and antagonists to modulate t cell responsesUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2839US2016193313A1Immunogenic compositions and methods for treating neoplasiaUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles G. Drake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →